TY - JOUR
T1 - Thrombosis of the superior vena cava due to a Hickman catheter: Successful management by rt-PA thrombolysis
AU - Zaccone, Maria Grazia
AU - Pafundi, Paolo D.
AU - Veneziani, Augusto
AU - Verbo, Alessandro
AU - Colli, Rosa
PY - 2017
Y1 - 2017
N2 - Introduction: Venous thrombosis is a frequent complication of long-term venous access. Its management is well defined in most cases, but some specific clinical situations have not yet been definitively standardized. Thrombosis may occur at the catheter tip and involve the superior vena cava (SVC) and/or the right atrium (RA). In such cases, while the need for a rapid intervention to relieve the venous obstruction and avoid embolism is obvious, the best management is still to be established. Case description: We report the case of a 25-year-old woman with symptomatic thrombosis of SVC and RA, associated with a Hickman catheter, which was successfully treated by recombinant tissue plasminogen activator (rt-PA). Conclusions: According to the literature, thrombolytic therapy with rt-PA may be considered the treatment of choice in symptomatic thrombosis of SVC secondary to long-term catheter, uncertainty still exists about dosage, optimal rate of infusion, and optimal duration of treatment, as well as the criteria for choosing local versus systemic infusion.
AB - Introduction: Venous thrombosis is a frequent complication of long-term venous access. Its management is well defined in most cases, but some specific clinical situations have not yet been definitively standardized. Thrombosis may occur at the catheter tip and involve the superior vena cava (SVC) and/or the right atrium (RA). In such cases, while the need for a rapid intervention to relieve the venous obstruction and avoid embolism is obvious, the best management is still to be established. Case description: We report the case of a 25-year-old woman with symptomatic thrombosis of SVC and RA, associated with a Hickman catheter, which was successfully treated by recombinant tissue plasminogen activator (rt-PA). Conclusions: According to the literature, thrombolytic therapy with rt-PA may be considered the treatment of choice in symptomatic thrombosis of SVC secondary to long-term catheter, uncertainty still exists about dosage, optimal rate of infusion, and optimal duration of treatment, as well as the criteria for choosing local versus systemic infusion.
KW - Adult
KW - Catheterization, Central Venous
KW - Central Venous Catheters
KW - Central venous catheter-related thrombosis
KW - Equipment Design
KW - Female
KW - Fibrinolytic Agents
KW - Humans
KW - Recombinant Proteins
KW - Superior Vena Cava Syndrome
KW - Superior vena cava syndrome
KW - Thrombolysis
KW - Thrombolytic Therapy
KW - Tissue Plasminogen Activator
KW - Tissue plasminogen activator
KW - Treatment Outcome
KW - Upper Extremity Deep Vein Thrombosis
KW - Vascular Patency
KW - Adult
KW - Catheterization, Central Venous
KW - Central Venous Catheters
KW - Central venous catheter-related thrombosis
KW - Equipment Design
KW - Female
KW - Fibrinolytic Agents
KW - Humans
KW - Recombinant Proteins
KW - Superior Vena Cava Syndrome
KW - Superior vena cava syndrome
KW - Thrombolysis
KW - Thrombolytic Therapy
KW - Tissue Plasminogen Activator
KW - Tissue plasminogen activator
KW - Treatment Outcome
KW - Upper Extremity Deep Vein Thrombosis
KW - Vascular Patency
UR - http://hdl.handle.net/10807/170008
U2 - 10.5301/jva.5000774
DO - 10.5301/jva.5000774
M3 - Article
SN - 1129-7298
VL - 18
SP - e92-e94
JO - Journal of Vascular Access
JF - Journal of Vascular Access
ER -